Paxil CR.(New and approved: Valtrex, Paxil CR)(Brief Article)
Publication: Internal Medicine News
Publication Date: 15-OCT-03
Author: Mechcatie, Elizabeth
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
A controlled-release formulation of the selective serotonin reuptake inhibitor (SSRI) for treating premenstrual dysphoric disorder. The third drug and the third SSRI approved for PMDD.
* Recommended Dosage: Starting at a daily dose of 12.5 mg throughout the cycle.
* Special Considerations: Paxil CR should not...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
